Skip to main content
. 2025 Mar 20;13(3):758. doi: 10.3390/biomedicines13030758
AMA African Medicines Agency
AdV Adenoviral
AVAREF African Vaccine Regulatory Forum
AAV Adeno-associated viral
CAR T cell Chimeric antigen receptor T cell
CGD Chronic granulomatous disease
CRISPR Clustered regularly interspaced short palindromic repeats
EMA European Medicine Agency
GMP Good manufacturing practice
HICs High-income countries
HSCs Hematopoietic stem cells
HSPC Hematopoietic stem and progenitor
LMICs Low-and middle-income countries
ML3 Maturity Level 3
IV Intravenous injection
LNPs Lipid nanoparticles
LMICs Low-and middle-income countries
SCD Sickle cell disease
SMA Spinal muscular atrophy
U.S. FDA United States Food and Drug Administration
VLPs Viral-like particles
WHO World Health Organization